DiagnOptics Technologies B.V.

DiagnOptics develops and markets a non-invasive diagnostic technology, which can assess the tissue accumulation of AGEs. Since 2006 the AGE Reader offers an immediate cardiovascular risk assessment that is essential in diabetes management. Diab-spot is a new and non-invasive test to identify people at risk for (pre)diabetes without overnight fasting, blood being drawn, or waiting hours for lab results. DiagnOptics will introduce the AGE Reader mu in 2013. The revolutionary AGE Reader mu combines the same high measurement quality standard with an innovative design at a reduced price level. The AGE Reader mu is a perfect tool for diabetologists and family doctors.

 

Diagnoptics AGE Reader mu small
Logodiagnoptics2013

DiagnOptics Technologies B.V.
L.J. Zielstraweg 1
9713 GX Groningen
Phone: +31 50 589 06 12
Contact: Piet van der Zee
info@diagnoptics.com
http://www.diagnoptics.com

Levels
  • Application developer
Products
  • Other
Markets
  • Biotechnology, Pharma & Agriculture
  • Health & Wellness
Competences
  • Test & Measurement technology
  • Optical systems